Holder plans sale of 11,345 IDEXX shares

A holder of IDEXX Laboratories common stock has filed a notice of proposed sale under Rule 144.

Rhea-AI Filing Summary

A holder of IDEXX Laboratories common stock has filed a notice of proposed sale under Rule 144. The filing covers 11,345 shares of common stock, with an aggregate market value of 7,336,994.15, to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 02/10/2026.

These 11,345 shares were acquired on 02/10/2026 via a stock option exercise from the issuer, paid in cash on the same date. The filing notes that 79,851,330 shares of the issuer’s common stock were outstanding, providing context for the size of the planned sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for IDXX disclose?

The Form 144 shows a planned sale of 11,345 IDEXX common shares under Rule 144. These shares, valued in total at 7,336,994.15, are to be sold on the NASDAQ through Morgan Stanley Smith Barney LLC around 02/10/2026.

How many IDEXX (IDXX) shares are planned to be sold and at what value?

The notice covers the proposed sale of 11,345 IDEXX common shares with an aggregate market value of 7,336,994.15. This reflects the estimated total market value of the transaction at the time the Form 144 was prepared.

How were the IDEXX shares in the Form 144 acquired?

The 11,345 IDEXX common shares were acquired on 02/10/2026 through a stock option exercise from the issuer. The filing states the exercise was paid for in cash, with the payment date also listed as 02/10/2026.

Which broker and exchange are involved in the IDXX Form 144 sale?

The planned sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The Form 144 indicates that the 11,345 IDEXX common shares are intended to be sold on the NASDAQ stock market around 02/10/2026.

How many IDEXX shares are outstanding compared to the amount in the Form 144?

The filing states that 79,851,330 IDEXX common shares were outstanding. The planned Rule 144 sale covers 11,345 shares, giving readers context on the relative size of this transaction versus the total shares outstanding.

What representation does the seller make in the IDXX Form 144?

By signing the notice, the seller represents that they do not know of any material adverse information about IDEXX’s current or prospective operations that has not been publicly disclosed, as required under the Rule 144 filing instructions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/10/2026 - 04:05 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001521861
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IDEXX LABORATORIES, INC.
SEC File Number	000-19271
Address of Issuer	One IDEXX Drive Westbrook MAINE 04092
Phone	207-556-0300
Name of Person for Whose Account the Securities are To Be Sold	GEORGE FENNELL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11345	7336994.15	79851330	02/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/10/2026	Stock Option Exercise	Issuer			11345	02/10/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ GEORGE FENNELL
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)